Even the most fit men can have hidden health risks that only deeper testing can unveil.
During my trip to Japan, I got a comprehensive preventive medical checkup of tests/screenings. Here's what it cost and how I ...
Eventually, the chatbots recommended Ursa Major brand cleanser and moisturizer. The cleanser is supposed to dry quickly and invisibly and have enough active cleaning power to cut through sunscreen, ...
If watching The Pitt is giving you a renewed interest in the human body in all of its gory glory, there’s a new tool that will help satisfy your curiosity. An international team of scientists ...
-- On track to report topline data from 12-patient Japanese cohort of setmelanotide Phase 3 trial in acquired HO in March 2026 -- -- On track to report topline data from Phase 3 EMANATE trial ...
BOSTON, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...
Distinct UV mutational signatures in cutaneous DNA reinforce UV radiation as the predominant environmental carcinogen underlying most skin cancers. Genetic counseling is best targeted to strong ...
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...
Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. For many people, the idea of a full-body skin check can feel intimidating. You may worry about ...
Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people. As many as one in two people aged over 60 suffer from some form of eczema. A ...
Eczema is a group of inflammatory and chronic skin conditions, and it is the most common skin disease among older people. As many as one in two people aged over 60 suffer from some form of eczema. A ...
-- Q4 2025 preliminary net product revenues from global sales of IMCIVREE ® (setmelanotide) of approximately $57 million for the fourth quarter of 2025, an 11% increase over Q3 2025 -- -- FY 2025 ...